Novo Nordisk (ETR: NOVC) said on Friday that its net profit in the fiscal third quarter came in better than expected. The company highlighted that patients in Europe and the United States stockpiled roughly £241.77 million worth of medicines in the fiscal first quarter amidst the ongoing COVID-19 crisis that has so far infected more than 45 million people worldwide and caused over 1.18 million deaths. Shares of the company slid more than 1% in premarket trading on Friday. Novo Nordisk is now exchanging hands at £50.58 per share after recovering from £42.51 per share in March. The Danish multinational
Full ArticleNovo Nordisk’s sales jump 2.1% to £3.74 billion in the fiscal third quarter
Invezz
0 shares
1 views
You might like
Related news coverage
Amazon’s sales jump 37% in the fiscal third quarter
Invezz
Amazon Inc. (NASDAQ: AMZN) said on Thursday that its revenue in the fiscal third quarter came in 37% higher on an annualised basis...
-
Apple Says Record 2020 Mac Sales Attributed Primarily to MacBook Pro
MacRumours.com
-
Facebook Posts Rare Drop in Active US Users But Beats Revenue Projections in Q3
The Wrap
-
NA Proactive news snapshot: ElectraMeccanica Vehicles, Willow Biosciences, DRDGOLD Limited, Aurania Resources UPDATE ...
Proactive Investors
-
Apple Reports 4Q 2020 Results: $12.7B Profit on $64.7B Revenue
MacRumours.com
Advertisement
More coverage
Gilead Sciences values its sales at £4.31 billion in the fiscal third quarter
Invezz
Gilead Sciences Inc. (NASDAQ: GILD) said on Wednesday that its profit and sales came in better than expected in the fiscal third..